Dual arginase inhibitor OATD-02 cleared to enter clinic for solid tumors
Nov. 29, 2022
Molecure SA has received clearance from the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products to conduct the first clinical trial of OATD-02.
